Joshua Cohen, MD
Joshua Cohen, MD, is a gynecologic oncologist with specialized training in gynecologic cancer treatment as well as clinical care and research. He offers a comprehensive and compassionate multidisciplinary approach to the treatment of gynecological malignancies including pre-invasive, invasive and advanced-stage gynecologic cancers. He has completed a fellowship in the treatment of women with gynecologic cancers including patients at high risk for ovarian and uterine cancers because of genetic mutations or strong family history, and of unknown etiology and concern for possible malignancy or difficult resection. Dr. Cohen is an expert in tumor cytoreduction and in the use of robotic surgery—including the state-of-the-art da Vinci® surgical system—and advanced laparoscopic procedures that reduce the need for open, more invasive surgical techniques for cancer care. He has distinguished himself in gynecologic cancer research and has completed the Clinical Research Training Program at the National Institutes of Health as well as the Clinical and Translational Science Institute certificate program at the David Geffen School of Medicine at UCLA. His research interests include the treatment of recurrent ovarian cancer and patient centered outcomes in gynecologic oncology. He serves patients in the greater Los Angeles area with offices in Westlake Village and Westwood offering a full range of oncology services and providing access to specialized research, clinical trials and diagnostic services.
Emma Rossi, MD
Emma Rossi, MD originates from Brisbane, Australia where she completed her undergraduate and medical school training at the University of Queensland. She graduated from an OBGYN residency at Northwestern University in Chicago, followed by a fellowship in Gynecologic Oncology at the University of North Carolina, at Chapel Hill. Following fellowship, Dr Rossi served as Assistant Professor of OGBYN at Indiana University where she was an Interim Fellowship Program Director in Gynecologic Oncology. In 2015 she returned to the University of North Carolina where she is faculty with the department of OBGYN. Dr Rossi has research and clinical interest and expertise in the minimally invasive surgical management of gynecologic cancers, with particular focus on robotic surgery and the development of novel techniques in sentinel lymph node mapping for endometrial and cervical cancers. She has published original articles in this subject matter, and serves as the principle investigator of the FIRES trial, which is a multi-institutional study, the largest of its kind, measuring the accuracy of sentinel node biopsy in diagnosing metastatic endometrial cancer. Dr Rossi has served as an invited speaker and surgeon nationally and internationally in robotic surgery and novel surgical techniques and has a passion for educating others regarding novel surgical techniques and minimally invasive surgery.
SGO gratefully acknowledges Intuitive Surgical for their generous unrestricted grant in support of this course.